Savicell Diagnostics
Blood Test for Early Cancer Detection
StartupSavicell Diagnostics is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 2012. Blood Test for Early Cancer Detection. Savicell Diagnostics was founded by Fernando Patolsky. The company has 1-10 employees. Core technologies: Biologicals, Cells.
The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePre-Funding
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQHaifa
- DistrictNorth District
- Last RoundUndisclosed
Fernando PatolskyPrincipal Investigator and Inventor
9 articles covered by sources including 13tv.co.il,
www.bioworld.com,
www.manufacturingchemist.com,
www.timesofisrael.com,
www.israel21c.org.
What does Savicell Diagnostics do?
Savicell Diagnostics develops the Well-Shield platform, a blood test designed for the early detection of disease, with a focus on cancer. The Well-Shield technology is designed to detect and interpret differential metabolic responses that can indicate disease intrusion and cell malformation, including cancer. The company aspires to improve adherence to routine medical screenings through the use of patient-friendly blood tests. Savicell Diagnostics is a majority-owned subsidiary of Savicell Corporation, a Nevada-based corporation.
Who founded Savicell Diagnostics?
Savicell Diagnostics was founded in 2012 by Fernando Patolsky (Principal Investigator and Inventor).
What sector is Savicell Diagnostics in?
Savicell Diagnostics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Test Diagnostics & Screening, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Savicell Diagnostics located?
Savicell Diagnostics is based in Matam, Haifa, Israel, North District.